Gene Therapy Market: size is expected to grow from US$ 4.86 Bn. in 2020 to US$ 27.21 Bn. by 2027, growing at a CAGR of 27.9% through 2021 to 2027. Spinal Muscular Atrophy (SMA) Indication segment leads the Global Gene Therapy Market by 2027.

Gene Therapy Market Overview:

Gene Therapy market was valued at US $4.86 Bn. in 2020, and it is expected to reach US $27.21 Bn. by 2027 with a CAGR of 27.9% during the forecast period. In the last ten years, gene therapy and new treatments based on gene therapy have made significant progress. For certain disorders, clinically effective gene treatments have been produced, and many additional potential medications have been discovered, with this trend especially obvious in the field of haematological diseases. Delivery vectors, gene engineering methods, and application to chimeric antigen receptor (CAR) T cell therapy are only a few of the recent advances in gene therapy and gene therapy-based approaches.

Gene Therapy Market Report 2020-2027 (Forecast Period) includes an analysis of market growth factors, future analysis, country-level, and regional-level analysis, market distribution, and competitive landscape analysis of major key competitors. Within the analysis report, each phase of the world global market is completely studied. The regional study of the global market will help you in gaining an understanding of the developments of the various geographic markets in recent years and moving ahead. The analysis also includes a wide-ranging synopsis of the key factors of the global market, like market influence and market result factors, drivers, threats, constraints, trends, restraints, and prospects. alternative methods of analysis, like qualitative and quantitative, are also used within the analysis study. Maximize Market Research team analysis provides a unique and in-depth report that helps you to perform detailed research on the global Gene Therapy market and make decisions on the future growth factors of the market. The market report provides an overview of the development of the Gene Therapy market throughout the forecasted period.

Request for free sample:

The Gene Therapy market report thoroughly covers insights of key competitors in terms of market, applications, and geographies that will help you in recognizing the competition both domestically as well as globally. The research mentions available micro-market investment options for investors and a full synopsis of the competitive landscape and significant products offered by industries.

The report also includes statistical data that consists of tables and charts which will further help you in business representation. Maximize Market Research also studies the current as well as new trends with the estimates of the market size throughout the forecasted period. Many competitors are also identified in various regions. The report provides PESTEL and Portal analysis too, which helps the clients to calculate every factor of the market.

Gene Therapy Market Segmentation:

Based on the Indication, the market is segmented into Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA), and Others. Spinal Muscular Atrophy (SMA) segment held the largest market share of 41% in 2020 and is expected to continue its dominance by 2027. Spinal Muscular Atrophy (SMA) is one of the most prevalent fatal hereditary disorders of childhood. The development of Zolgensma (AVXS-101) as a gene therapy has demonstrated its efficacy in treating SMA and modifying the disease phenotype. The FDA granted Novartis approval for Zolgensma, a drug aimed to treat the underlying cause of SMA, in May 2019. In this segment, Zolgensma is the first and only approved gene treatment.

Gene Therapy Market Key Players: 

• Bayer
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• Applied Genetic Technologies Corp
• F. Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc;
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd
• Gensight Biologics S.A.
• Transgene
• Calimmune, Inc
• Epeius Biotechnologies Corp
• Astellas Pharma, Inc
• American Gene Technologies
• BioMarin Pharmaceuticals, Inc.
• Human Stem Cell Institute
• Spark Therapeutics LLC
• GlaxoSmithKline
• Voyager Therapeutics

Get Report Details:

Gene Therapy Market Regional Analysis:

Based on the regions the market is studied across

Asia-Pacific (Vietnam, Malaysia, Korea, China, Philippines, Thailand, Indonesia, and India, Japan, Australia, ). Africa and the Middle East (Egypt and GCC Countries.). North America (Canada, the United States, and Mexico.). South America (Brazil etc). Europe (France, Italy, Germany, Russia, UK, Turkey, etc.).

IMPACT Of COVID-19 On The Gene Therapy Market:

COVID-19 has impacted the world with its fast-spreading effects all over the world. It has impacted every industry and business except for the medical and health care industry which is working 24/7 to stop the spread of the COVID-19 virus, they are working hard to save the lives of people affected by this virus. As mentioned many industries are suffering in this COVID-19 times, our market is also one of them. Our team here at Maximize Market Research has worked hard to provide solutions to these issues that will help your business.

About Us:

Maximize Market Research provides B2B and B2C research on more than 12,000 high growth emerging opportunities technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics Communications, Internet of Things, Food and Beverages, Aerospace and Defense, and other manufacturing sectors.

Contact Us:


3rd Floor, Navale IT Park Phase 2,

Pune Bengaluru Highway,

Narhe, Pune, Maharashtra 411041, India.


Phone No.: +91 20 6630 3320